Effect of Prostaglandins I2 and E1 on Red Cell Deformability in Patients With Raynaud's Phenomenon and Systemic Sclerosis.

BMJ

doi 10.1136/bmj.283.6287.350

Full Text

Abstract

Available in

Date

Authors

Publisher

BMJ

Related search

Prostaglandins I2 and E1 and Red Cell Deformability in Raynaud's Phenomenon and Systemic Sclerosis

BMJ
1981English

Recount of Prostaglandin E1 Therapy in a Patient With Raynaud's Phenomenon

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Infusion of Iloprost, a Prostacyclin Analogue, for Treatment of Raynaud's Phenomenon in Systemic Sclerosis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1988English

Raynaud's Phenomenon and Hand Function in Patients With Rheumatoid Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2010English

The Efficacy of Nailfold Capillaroscopy in Patients With Raynaud's Phenomenon

Journal of Rheumatic Diseases
2015English

Autohaemagglutination and Raynaud's Phenomenon

BMJ
1947English

Raynaud's Phenomenon

Nurse Prescribing
2017English

A Woman With Dysphagia and Raynaud's Phenomenon

Postgraduate Medical Journal
Medicine
2002English

Assessment and Management of Raynaud's Phenomenon

Prescriber
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy